Given our observation that MKP-5 deficiency enhances MAPK activity in cardiac muscle from exercised mice, it is plausible that MKP-5-mediated regulation of the MAPK signaling pathway contributes to the activation of the Akt/mTOR signaling pathway, thereby promoting physiological cardiac hypertrophy. The gene discussed is AKT1; the disease is cardiac hypertrophy.